Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults.

scientific article published in September 2006

Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10038-006-0043-Z
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s10038-006-0043-z
P698PubMed publication ID16946993
P5875ResearchGate publication ID6842268

P50authorEugene Haydn WaltersQ40873493
Michael J. AbramsonQ43297739
Melanie C MathesonQ57317696
David P JohnsQ57318027
Justine A. EllisQ73199090
P2093author name stringJoan Raven
P2860cites workAssociation between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezingQ24561362
Interpretative strategies for lung function testsQ28279970
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryQ29614692
Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based studyQ33759245
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthmaQ33910403
The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locusQ34142171
Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotypeQ34208106
Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokersQ35536131
Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary diseaseQ35537864
The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterolQ35825894
Pathophysiology of airflow limitation in chronic obstructive pulmonary diseaseQ35869635
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessQ37248530
Polymorphisms of IL4, IL13, and ADRB2 genes in COPD.Q39062161
An efficient procedure for genotyping single nucleotide polymorphisms.Q39098483
Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.Q40812511
beta(2)-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the HutteritesQ43523028
Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smokingQ43616373
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitizationQ43756517
Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsivenessQ44555530
Beta 2-adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men.Q44975066
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialQ45121026
Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adultsQ46990728
Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult populationQ47924630
Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects.Q49194277
Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study.Q50853548
Airways responsiveness and development and remission of chronic respiratory symptoms in adults.Q50923941
HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes.Q52332067
Spirometric standards for healthy adult lifetime nonsmokers in Australia.Q52342868
Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness.Q54062682
Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.Q54169189
Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.Q54197421
beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and childrenQ57253792
Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmaticsQ57416150
Toward a definition of asthma for epidemiologyQ68037965
Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjectsQ72956092
Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort studyQ73176245
Polymorphisms of the beta2-adrenergic receptor and asthmaQ73833180
Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapyQ74462919
Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthmaQ74575496
Polymorphism of the beta(2)-adrenoceptor in COPD in Chinese subjectsQ77190874
beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthmaQ77217926
P433issue11
P921main subjectasthmaQ35869
chronic obstructive pulmonary diseaseQ199804
P304page(s)943-951
P577publication date2006-09-01
P1433published inJournal of Human GeneticsQ6295302
P1476titleBeta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults
P478volume51

Reverse relations

cites work (P2860)
Q52626684A functional SNP upstream of the ADRB2 gene is associated with COPD.
Q36182193ADRB2 polymorphisms and budesonide/formoterol responses in COPD.
Q36787432Airway smooth muscle in the pathophysiology and treatment of asthma
Q37102319Association between polymorphisms in the beta2-adrenoceptor gene and migraine in women
Q35457640Association between β2-Adrenergic Receptor-16Arg/Gly Gene Polymorphism and Chronic Obstructive Pulmonary Disease Risk:Systematic Review and Meta-Analysis
Q31172592Association between β2-adrenoceptor gene polymorphisms and asthma risk: an updated meta-analysis
Q46654964Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Q37595504Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors.
Q59804749Beta 1, Beta 2 and Beta 3 Adrenergic Receptor Gene Polymorphisms in a Southeastern European Population
Q33957027Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context
Q36916960Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design
Q34599761Comparison of spirometric changes in the response to bronchodilators of patients with asthma or chronic obstructive pulmonary disease
Q37357856Effects of in utero and childhood tobacco smoke exposure and beta2-adrenergic receptor genotype on childhood asthma and wheezing
Q37562317Gene polymorphisms and chronic obstructive pulmonary disease
Q37351330Genetic association analysis of COPD candidate genes with bronchodilator responsiveness
Q36464198Glucocorticoid receptor gene polymorphisms and potential association to chronic obstructive pulmonary disease susceptibility and severity
Q40398959Lung Development and Aging
Q46085187Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease
Q38495339Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.
Q36838782Update in chronic obstructive pulmonary disease 2006.
Q26824935Updates on the COPD gene list
Q36784448Variability in small airway epithelial gene expression among normal smokers.
Q39307440Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.

Search more.